| Identification | Back Directory | [Name]
2,3-Dihydro-methyl-5-benzofuranethanaminehydrochloride | [CAS]
152623-94-4 | [Synonyms]
5-APDB
5-APDB (hydrochloride)
5-(2-AMinopropyl)-2, 3-dihydrobenzofuran
5-(2-AMINOPROPYL)-2,3-DIHYDROBENZOFURAN HYDROCHLORIDE
2,3-Dihydro-methyl-5-benzofuranethanaminehydrochloride
2,3-Dihydro-α-methyl-5-benzofuranethanamine Hydrochloride
1-(2,3-dihydro-1-benzofuran-5-yl)propan-2-amine:hydrochloride
2,3-Dihydro-alpha-methyl-5-benzofuranethanamine hydrochloride
2,3-Dihydro-α-methyl-5-benzofuranethanamine hydrochloride (1:1)
5-BenzofuranethanaMine, 2,3-dihydro-alpha-Methyl-, hydrochloride
1-(2,3-Dihydro-1-benzofuran-5-yl)-2-propanaMine hydrochloride (1:1) | [Molecular Formula]
C11H15NO.HCl | [MDL Number]
MFCD18380763 | [MOL File]
152623-94-4.mol |
| Hazard Information | Back Directory | [Description]
5-APDB is an entactogen belonging to the amphetamine and the phenethylamine classes. It is an analog of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene group. 5-APDB can inhibit serotonin, dopamine and norepinephrine reuptake with IC50 values of 0.13, 7.1, and 3.2 μM, respectively, and generalizes closely to the non-stimulant MDMA analogs, MBDB and MMAI, in drug discrimination studies. This product is intended for forensic purposes. | [Uses]
2,3-Dihydro-α-methyl-5-benzofuranethanamine is a stimulant and entactogen drug of phenethylamine and amphetamine classes. 2,3-Dihydro-α-methyl-5-benzofuranethanamine is also an analog of 3,4-Methylene
dioxyamphetamine (M303965), a psychedlic drug that exhibits inhibitory actions towards the reuptake of serotonin. |
|
|